| Symbol | Mkt Cap | P/E | Current Ratio | Cash per Share | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | H-Rank | C-Rank | h-rank |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | 124 B | 10.0 | 1.3 | 5.24 | 28 | 39 | 1.3 | 1392 | 23 | 1 | 33 |
| AMGN | 202 B | 16 | 1.1 | 16.93 | 30 | 45 | 8.6 | 112 | 23 | 2 | 30 |
| GILD | 188 B | 15 | 1.7 | 8.55 | 37 | 49 | 4.7 | 23 | 22 | 2 | 42 |
| LLY | 952 B | 24 | 1.6 | 8.14 | 44 | 48 | 42 | 51 | 19 | 2 | 51 |
| NVO | 211 B | 13 | 0.80 | 6.07 | 44 | 49 | -7.6 | -4.7 | 27 | 2 | 23 |
| GSK | 119 B | 11 | 0.82 | 0.85 | 16 | 40 | 6.2 | 55 | 25 | 3 | 43 |
| JNJ | 584 B | 19 | 1.00 | 8.34 | 23 | 35 | 9.1 | 48 | 25 | 3 | 27 |
| MRK | 305 B | 12 | 7.34 | 32 | 44 | 5.0 | -19 | 27 | 3 | 39 | |
| NVS | 314 B | 16 | 1.1 | 6.04 | 27 | 41 | 2.2 | -11 | 27 | 3 | 44 |
| ABBV | 397 B | 13 | 3.21 | 34 | 48 | 10.0 | 33 | 5 | 51 | ||
| AZN | 317 B | 34 | 0.94 | 3.70 | 19 | 33 | 4.1 | 54 | 28 | 5 | 39 |
| GRFS | 7.8 B | 7.9 | 2.5 | 1.21 | 20 | 23 | 4.0 | 30 | 5 | 46 | |
| BIIB | 28 B | 11 | 2.7 | 26.00 | 19 | 36 | -7.1 | 31 | 6 | 43 | |
| PFE | 152 B | 9.4 | 2.64 | 24 | 41 | -1.2 | 36 | 6 | 45 | ||
| SNY | 114 B | 8.8 | 1.1 | 6.36 | 14 | 27 | 6.9 | 34 | 6 | 49 | |
| OGN | 2.1 B | 2.2 | 2.58 | 15 | 26 | -5.3 | 38 | 7 | 58 | ||
| AMRN | 324 M | 26 | 3.4 | 0.69 | -3.4 | -10.0 | 17 | 48 | 19 | 48 | |
| MIRA | 50 M | -2.9 | 90 | 0.18 | 0.00 | 0.00 | 48 | 21 | 61 | ||
| SCLX | 57 M | 2.6 | 0.05 | 0.15 | -1766 | 0.00 | -26 | 58 | 29 | 71 | |
| MDCX | 30 M | -0.80 | 0.92 | 0.39 | 0.00 | 0.00 | 60 | 30 | 74 | ||
| NSRX | 69 M | 0.06 | 0.03 | 0.00 | 0.00 | 71 | 45 | 48 | |||
| Q1=9.4 | Q3=1.7 | Q3=30.0 | Q3=44.0 | Q3=8.6 | Q3=55.0 | Q1=39.0 |
| Total Records: 21. | Quotes | Help |
| © George Elgin | Questions or Comments | Data last Modified 02/22/26 |